Expression of cyclin E in human gastric adenomas and adenocarcinomas: Correlation with proliferative activity and p53 status

Journal of Experimental Therapeutics and Oncology

Volumn 1, Issue 2, 1996, Pages 88-94

  Yasui, W ^a   Akama, Y ^a   Kuniyasu, H ^a   Yokozaki, H ^a   Semba, S ^a   Shimamoto, F ^b   Tahara, E ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cyclin E; Gastric adenoma; Gastric carcinoma; Ki 67; p53

Indexed keywords

CYCLIN E; KI 67 ANTIGEN; PROTEIN P53;

ADENOCARCINOMA; ADENOMA; ARTICLE; BIOSYNTHESIS; CELL DIVISION; DISEASE COURSE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; STOMACH TUMOR;

ADENOCARCINOMA; ADENOMA; CELL DIVISION; CYCLIN E; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030088926     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sherr CJ. G1 phase progression: Cycling on cue. Cell 79: 515-555, 1994.
2. Hunter T, Pines J. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994.
3. El-Deiry WS, TokinoT, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-625, 1993.
4. HarperJW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
5. KIP1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Gene Dev 8: 9-22, 1994.
6. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74, 1994.
7. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440, 1994.
8. INK4B is a potent effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261, 1994.
9. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756, 1994.
10. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707, 1993.
11. Buckley MF, Sweeney KJ, Hamilton JA, et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133, 1993.
12. Leach FS, Elledge SJ, Sherr CJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B. Amplification of cyclin genes in colorectal carcinomas. Cancer Res 53: 1986-1989, 1993.
13. Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci (USA) 90: 1112-1116, 1993.
14. Keyomarsi K, O'leary N, Molnar G, Lees E, Fingert HJ, Pardee AB. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54: 380-385, 1994.
15. Geng Y, Weinberg RA. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci (USA) 90: 10315-10319, 1993.
16. Akama Y, Yasui W, Yokozaki H, Kuniyasu H, Kitahara K, Ishikawa T, Tahara E. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 86: 617-621, 1995.
17. Kitahara K, Yasui W, Kuniyasu H, et al. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas. Int J Cancer 62: 25-28, 1995.
18. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma, First English edition, Kanehara, Tokyo, 1995.
19. Yasui W, Ji Z-Q, Kuniyasu H, Ayhan A, Yokozaki H, Ito H, Tahara E. Expression of transforming growth factor alpha in human tissues: immunohistochemical study and Northern blot analysis. Virchows Arch A Pathol Anat 421: 513-519, 1992.
20. Weidner N, Moore DH, Vartanian R. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel 'paraffin'-reactive MIB1 antibody. Human Pathol 25: 337-342, 1994.
21. Heichman KA, Roberts JM. Rules to replicate by. Cell 79: 557-562, 1994.
22. Resnitzky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclin D1 and E with an inducible system. Mol Cell Biol 14: 1669-1679, 1994.
23. Wimmel A, Lucibello FC, Sewing A, Adolph S, Muller R. Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene 9: 995-997, 1994.
24. Barak Y, Gottlieb E, Juven-Gershon T, Oren M. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Gene Dev 8: 1739-1749, 1994.
25. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299, 1995.
26. Smith ML, Chen I-T, Zhan Q, et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266: 1376-1380, 1994.
27. Yokozaki H, Kuniyasu H, Kitadai Y, et al. p53 point mutations in primary human gastric carcinomas. J Cancer Res Clin Oncol 119: 67-70, 1992.
28. Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993.
29. Ayhan A, Yasui W, Yokozaki H, Ito H, Tahara E. Genetic abnormalities and expression of p53 in human colon carcinomas. Int J Oncol 1: 431-437, 1992.
30. Spruck CHI, Gonzales-Zulueta M, Shibata A, et al. p16 gene in uncultured tumours. Nature 370: 183-184, 1994.
31. Mori T, Miura K, Aoki T, Nishihara T, Mori S, Nakamura M. Frequent somatic mutation of MTS1/ CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54: 3396-3397, 1994.
32. MST1 gene status in human esophageal carcinoma cell lines. J Exp Therap Oncol 1: 6-12, 1996.